Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China

Bo Li1, Ning Gao2,3, Zhuang Zhang4,5

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. li_yi@scu.edu.cn.

Genes
|March 2, 2017
PubMed

Insights

Gene therapy offers a promising approach to treating diseases like cancer. This review details the history and development of gene therapy clinical trials in China, covering protocols and outcomes.

Area of Science:

  • Oncology
  • Genetics
  • Medical Research

Background:

  • Gene therapy, a promising medical treatment, has a nearly 27-year history since its first authorized study in 1989.
  • Despite its potential, gene therapy adoption was slow globally until recently.
  • China has been actively conducting gene therapy clinical trials since 1998, contributing significantly to medical research.

Purpose of the Study:

  • To review the history of gene therapy in China.
  • To provide comprehensive information on treatment protocols, administration cycles, dosage calculations, and therapeutic effect evaluations.
  • To support the further development of gene therapy as a treatment strategy.

Main Methods:

  • Historical review of gene therapy clinical trials in China.
  • Analysis of treatment protocols and administration parameters.
  • Evaluation of therapeutic effects and outcomes.

Main Results:

  • Gene therapy research has flourished in China since 1998.
  • Established protocols for gene therapy administration and dosage calculation exist.
  • Therapeutic effects of gene therapy have been evaluated.

Conclusions:

  • Gene therapy is a developing and promising treatment strategy for various diseases.
  • China's contributions to gene therapy research are substantial.
  • Further development of gene therapy can be informed by this review of Chinese clinical trials.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K